SDC1 and Miyoshi myopathy: Overall, MM burden at the end of the experiment was higher in the BTK-KD group than in the control group, based on measurements of circulating human immunoglobulins (4.3-fold higher; P<0.03) and soluble syndecan-1 levels (2.3-fold higher; P<0.03; Figure 2d).